Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

28.72 -0.42 (-1.44%)
Streaming Delayed Price Updated: 2:28 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
TG Therapeutics Stock 300% Rally Has Legs Yet
There's further upside in the region of 30% yet to be realized, which should be more than enough to get even the more risk averse investor interested. 
Via MarketBeat
News headline image
Here's How Much $100 Invested In TG Therapeutics 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
The Latest Analyst Ratings for TG Therapeutics ↗
 
Via Benzinga
Here's How Much $1000 Invested In TG Therapeutics 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
'A Class Action Lawsuit Against TG Therapeutics Has Been Dismissed' ↗
https://www.docdroid.com/05I9eLb/tg-therapeutics-class-action-dismissal-pdf https://twitter.com/TradeHawk/status/1613997810348879874 
Via Benzinga
News headline image
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank? ↗
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
News headline image
Why TG Therapeutics Stock Was a Solid Winner This Week ↗
The company scored a giant victory on the regulatory front. 
Via The Motley Fool
News headline image
Analyst Ratings for TG Therapeutics ↗
 
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday ↗
Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday. 
Via Benzinga
News headline image
Shaw Communications, Enovix And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets ↗
Wednesday, the FDA approved TG Therapeutics Inc's (NASDAQ: TGTX) Briumvi (ublituximab-xiiy) for relapsing forms of multiple sclerosis (RMS). 
Via Benzinga
News headline image
B of A Securities Maintains Underperform Rating for TG Therapeutics: Here's What You Need To Know ↗
 
Via Benzinga
TG Therapeutics Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Why Shares of TG Therapeutics Climbed 59.9% This Week ↗
The company got a big bump from the FDA. 
Via The Motley Fool
News headline image
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. 
Via Benzinga
News headline image
What's Going On With TG Therapeutics Shares ↗
TG Therapeutics Inc (NASDAQ: TGTX) shares are trading higher by 9.34% to $9.25 Thursday morning. The company on Wednesday revealed FDA approval of ublituximab. What's Happening? 
Via Benzinga
News headline image
Tesla To $250? Here Are 10 Other Price Target Changes For Thursday ↗
Morgan Stanley cut Tesla, Inc. (NASDAQ: TSLA) price target from $330 to $250. Morgan Stanley analyst Adam Jonas maintained an Overweight rating on the stock. Tesla shares rose 4.4% to $117.65 in... 
Via Benzinga
News headline image
Why TG Therapeutics' Shares Rose 63.37% on Thursday ↗
The company had a nugget of good news in its third-quarter report. 
Via The Motley Fool
News headline image
Tesla, Hyzon Motors And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket ↗
Gainers Quotient Limited (NASDAQ: QTNT) shares rose 125% to $0.54 in pre-market trading after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the... 
Via Benzinga
News headline image
Pfizer Makes Progress, but This Biotech Was Wednesday's Big Winner ↗
The stock market lost ground as economic worries persist. 
Via The Motley Fool
News headline image
Here's Why TG Therapeutics (TGTX) Shares Are Skyrocketing ↗
TG Therapeutics Inc (NASDAQ: TGTX) shares are trading higher by 8.82% to $8.51 Wednesday afternoon following FDA approval of ublituximab. What's Happening? 
Via Benzinga
News headline image
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal... 
Via Benzinga
News headline image
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors ↗
Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%. 
Via Benzinga
News headline image
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Dow Jumps Over 1,000 Points; Digital Turbine Shares Spike Higher ↗
U.S. stocks traded sharply higher toward the end of trading, with the NASDAQ Composite jumping over 6% on Thursday. 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.